Whole blood stability evaluation of monoclonal antibody therapeutics using volumetric absorptive microsampling.

Bioanalysis

Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield CT 06877, USA.

Published: April 2021

Volumetric absorptive microsampling (VAMS) is increasingly utilized for both nonclinical and clinical pharmacokinetic studies. Currently, VAMS is employed as the sampling method for the detection of antibodies for coronavirus disease 2019. Biotherapeutics whole blood stability on VAMS presents as a critical concern for the health and pharmaceutical industries. In this follow-up to our previous publication, we evaluated daclizumab and trastuzumab whole blood sample stability on VAMS. The drug recovery data we observed at room temperature for short term and -80°C for long term was very encouraging. The knowledge could help us better understand and plan important investigation timelines, especially pandemic situations where human whole blood samples from a large population are collected and in urgent need of data analysis.

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio-2021-0025DOI Listing

Publication Analysis

Top Keywords

blood stability
8
volumetric absorptive
8
absorptive microsampling
8
stability vams
8
blood
4
stability evaluation
4
evaluation monoclonal
4
monoclonal antibody
4
antibody therapeutics
4
therapeutics volumetric
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!